The biggest loser by far was PBX:Probiotix Health, which dropped
25% after uninspiring results and is now 85% down. This is going to continue
to be a disaster for some time now, as there was absolutely nothing in the
investor presentation that suggested an increase in sales of any magnitude.
AFC:AFC Energy gave up 7% of last week's gains and I suspect will
remain volatile for a while.
IES:Invinity Energy has been on a mini surge, climbing 7% this week. My
recent purchase is only 7% down now, but my original holding is still 87%
down. I need it to get from 22p to 62p for the two holdings to cancel each
other out and allow me to sell without a loss and liberate £1,800. However, if
it does get to 62p then that suggests things are going well and I may hold
them a bit longer.
TRX:Tissue Regenix have really woken up lately, and went up 8% this
week so my holding is only 49% down and I can change its colour from crimson
to orange/red.
CWR:Ceres Power went up 9% for no particular reason. It seems to bounce
in a 30% range quite frequently. My holding is down by 5% now.
FXPO:Ferrexpo have been climbing steadily as it appears production and sales
are getting back to normal. It would have been a great buy at the lowest
point, but one Russian missile could end everything. My holding is still 88% down
despite the 14% rise this week.
SAE:Simec Atlantis Energy has definitely returned to my normal share list and
went up 33% this week so my holding is only 70% down. Considering I'd given it
up as a basket case. that's quite a relief.
Share of the Week by a mile is OPTI:Optibiotix which rocketed up by 62% after
a Midas share tip. Slightly galling that it's taken the Daily Mail to help me
reduce my losses, but I'll take anything at the moment.
Here's the ISA and shares portfolio after week 50 of year 9.
Weekly Change | |||
Cash | £65.34 | +£0 | |
Portfolio cost | £104,946.57 | +£0 | |
Portfolio sell value (bid price-commission) |
£53,406.98 | (-49.1%) | +£10,516.44 |
Potential profits | £1,548.67 | +£1,131.42 | |
Yr 9 Dividends | £296.50 | +£0 | |
Yr 9 Interest | £4.87 | +£0 | |
Yr 9 Profit from sales | £536.46 | +£0 | |
Yr 9 proj avg monthly profit | £65.26 | (1.0%) | -£1.34 |
Total Dividends | £12,207.93 | +£0 | |
Total Interest | £6.80 | +£0 | |
Total Profit from sales | £17,834.99 | +£0 | |
Average monthly cash profit | £275.13 | (4.4%) | -£0.59 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Compound performance | 39% | +0% |
Massive increase in value of £10,516 and potential profits increased by £1,131, with all of that down to OPTI:Optibiotix, as JLP:Jubilee Metals stayed flat.
Up to the highest level for about 6 months, although there has been a cash injection since then.
Blasted above the trend line. Just need the momentum to continue like it did 12 months ago.
The SIPP looks like this after week 450 overall and week 34 of year 9.
Weekly Change | ||||
Cash | £529.59 | -£167.89 |
||
Portfolio cost | £110,693.69 | +£235.87 | ||
Portfolio sell value (bid price - commission) |
£64,067.41 | (-42.1%) | +£9,280.71 | |
Potential profits | £3,511.80 | -£12.48 | ||
Yr 9 Dividends | £855.58 | +£67.98 | ||
Yr 9 Interest | £4.04 | +£0 | ||
Yr 9 Profit from sales | £4,684.03 | +£0 | ||
Yr 9 proj avg monthly profit | £687.82 | (11.3%) | -£11.92 | |
Total Dividends | £15,490.46 | +£67.98 | ||
Total Interest | £9.97 | +£0 | ||
Total Profit from sales | £15,519.93 | +£0 | ||
Average monthly cash profit | £286.16 | (4.7%) | +£0.02 | |
(Sold stocks profit + Dividends - Fees / Months) |
||||
Compound performance | 41% | +1% |
I got a £39 dividend from PLUS:Plus 500 and £28 from PSN:Persimmon, and I also did my monthly investment which has now switched to EDV:Endeavour Mining. I bought 13 shares at 1793.8313p costing £235.87.
Massive increase in portfolio value, but a small drop in potential profits as
my OPTI:Optibiotix holding is still making a loss, and the 7% drop in AFC:AFC
Energy offset small gains elsewhere. My cheapest OPTI holdings are down by 27%
and 32%, but I will probably sell both when they move into profit as I
transfer the SIPP holdings to dividend-paying companies. I have 121,610 shares
in my ISA and 106,046 in my SIPP, so I would be almost halving my holding, but
I need to be strict with my new strategy.
As with the ISA, a sharp up-turn
The trend line isn't as steep in the SIPP so I have a much better chance of dragging it flat.
The trading account looks like this after week 416 overall and week 52 of year 8.
Weekly Change | |||
Cash | £63.39 | +£0 | |
Portfolio cost | £2,073.87 | +£0 |
|
Portfolio sell value (bid price - commission) |
£1,391.20 | (-32.9%) | +£0 |
Potential profits | £56.30 | +£0 | |
Year 8 Dividends | £25.36 | +£0 | |
Year 8 Interest | £0 | +£0 | |
Year 8 Profit | £328.15 | +£0 | |
Yr 8 proj avg monthly profit | £29.46 | (+17.0%) | -£0.58 |
Dividends | £85.46 | +£0 | |
Interest | £0.03 | +£0 | |
Profit from sales | -£602.54 | +£0 | |
Average monthly cash profit | -£5.39 | (-3.1%) | +£0.01 |
(Sold stocks profit + Dividends - Fees / Months) |
Long term performance is still negative, so I do need to target making over
£612 profit in year 9, which is almost twice what I was able to make in year
8.
I still need copper production news from JLP:Jubilee Metals and a Croda deal for SBTX:SkinBioTherapeutics.
Sitting on the trend line. Will it be above or below next week?
I really don't know if the rise in OPTI:Optibiotix will be sustained, or just
start drifting back down like it has for the last 12 months. I'm just relieved
that I don't have to report losses greater than portfolio value any more. That
should really be my minimum goal.
I have a £2,000 pension transfer coming through next week. It the moment I'm thinking of CAPD:Capital and ALU:Alumasc. I already own CAPD in a dealing account but will sell that as soon as in profit if I also hold it in my SIPP, and I've been watching ALU for years, and they have a good dividend, so it's about time I invested. I want to increase my CAML:Central Asia Metals holding, but will do that from the proceeds of sales of AFC:AFC Energy and JLP:Jubilee Metals when they get into profit.
You might find this ETF interesting for dividend payments, dividend growth and underlying capital growth.
ReplyDeleteVanEck Morningstar Developed Market Dividend Leaders
(TDGB)